Interestingly, we also observed a CD4+CD25−FoxP3+ tumour cell population, which was also significantly reduced in the pEEVGmCSF-b7.1-treated animals when compared with untreated tumours (P<0.05), and also in the therapeutic control pGT141GmCSF-b7.1. The gene discussed is CD4; the disease is neoplasm.